Report Detail
Global Remicade Biosimilar Market Professional Survey Report 2019
- RnM3784816 |
- 26 September, 2019 |
- Global |
- 107 Pages |
- QYResearch |
- Pharma & Healthcare
Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product.
The global Remicade Biosimilar market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Remicade Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Remicade Biosimilar market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Remicade Biosimilar in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Remicade Biosimilar manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
100mg/10ml
500mg/50ml
Segment by Application
Blood Disorders
Oncology Diseases
Table of Contents
Executive Summary
1 Industry Overview of Remicade Biosimilar
- 1.1 Definition of Remicade Biosimilar
- 1.2 Remicade Biosimilar Segment by Type
- 1.2.1 Global Remicade Biosimilar Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 100mg/10ml
- 1.2.3 500mg/50ml
- 1.3 Remicade Biosimilar Segment by Applications
- 1.3.1 Global Remicade Biosimilar Consumption Comparison by Applications (2014-2025)
- 1.3.2 Blood Disorders
- 1.3.3 Oncology Diseases
- 1.4 Global Remicade Biosimilar Overall Market
- 1.4.1 Global Remicade Biosimilar Revenue (2014-2025)
- 1.4.2 Global Remicade Biosimilar Production (2014-2025)
- 1.4.3 North America Remicade Biosimilar Status and Prospect (2014-2025)
- 1.4.4 Europe Remicade Biosimilar Status and Prospect (2014-2025)
- 1.4.5 China Remicade Biosimilar Status and Prospect (2014-2025)
- 1.4.6 Japan Remicade Biosimilar Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Remicade Biosimilar Status and Prospect (2014-2025)
- 1.4.8 India Remicade Biosimilar Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Remicade Biosimilar
- 2.3 Manufacturing Process Analysis of Remicade Biosimilar
- 2.4 Industry Chain Structure of Remicade Biosimilar
3 Development and Manufacturing Plants Analysis of Remicade Biosimilar
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Remicade Biosimilar Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Remicade Biosimilar
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Remicade Biosimilar Production and Capacity Analysis
- 4.2 Remicade Biosimilar Revenue Analysis
- 4.3 Remicade Biosimilar Price Analysis
- 4.4 Market Concentration Degree
5 Remicade Biosimilar Regional Market Analysis
- 5.1 Remicade Biosimilar Production by Regions
- 5.1.1 Global Remicade Biosimilar Production by Regions
- 5.1.2 Global Remicade Biosimilar Revenue by Regions
- 5.2 Remicade Biosimilar Consumption by Regions
- 5.3 North America Remicade Biosimilar Market Analysis
- 5.3.1 North America Remicade Biosimilar Production
- 5.3.2 North America Remicade Biosimilar Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Remicade Biosimilar Import and Export
- 5.4 Europe Remicade Biosimilar Market Analysis
- 5.4.1 Europe Remicade Biosimilar Production
- 5.4.2 Europe Remicade Biosimilar Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Remicade Biosimilar Import and Export
- 5.5 China Remicade Biosimilar Market Analysis
- 5.5.1 China Remicade Biosimilar Production
- 5.5.2 China Remicade Biosimilar Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Remicade Biosimilar Import and Export
- 5.6 Japan Remicade Biosimilar Market Analysis
- 5.6.1 Japan Remicade Biosimilar Production
- 5.6.2 Japan Remicade Biosimilar Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Remicade Biosimilar Import and Export
- 5.7 Southeast Asia Remicade Biosimilar Market Analysis
- 5.7.1 Southeast Asia Remicade Biosimilar Production
- 5.7.2 Southeast Asia Remicade Biosimilar Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Remicade Biosimilar Import and Export
- 5.8 India Remicade Biosimilar Market Analysis
- 5.8.1 India Remicade Biosimilar Production
- 5.8.2 India Remicade Biosimilar Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Remicade Biosimilar Import and Export
6 Remicade Biosimilar Segment Market Analysis (by Type)
- 6.1 Global Remicade Biosimilar Production by Type
- 6.2 Global Remicade Biosimilar Revenue by Type
- 6.3 Remicade Biosimilar Price by Type
7 Remicade Biosimilar Segment Market Analysis (by Application)
- 7.1 Global Remicade Biosimilar Consumption by Application
- 7.2 Global Remicade Biosimilar Consumption Market Share by Application (2014-2019)
8 Remicade Biosimilar Major Manufacturers Analysis
- 8.1 Synthon Pharmaceuticals
- 8.1.1 Synthon Pharmaceuticals Remicade Biosimilar Production Sites and Area Served
- 8.1.2 Synthon Pharmaceuticals Product Introduction, Application and Specification
- 8.1.3 Synthon Pharmaceuticals Remicade Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 LG Life Sciences
- 8.2.1 LG Life Sciences Remicade Biosimilar Production Sites and Area Served
- 8.2.2 LG Life Sciences Product Introduction, Application and Specification
- 8.2.3 LG Life Sciences Remicade Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Novartis (Sandoz)
- 8.3.1 Novartis (Sandoz) Remicade Biosimilar Production Sites and Area Served
- 8.3.2 Novartis (Sandoz) Product Introduction, Application and Specification
- 8.3.3 Novartis (Sandoz) Remicade Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Celltrion
- 8.4.1 Celltrion Remicade Biosimilar Production Sites and Area Served
- 8.4.2 Celltrion Product Introduction, Application and Specification
- 8.4.3 Celltrion Remicade Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Biocon
- 8.5.1 Biocon Remicade Biosimilar Production Sites and Area Served
- 8.5.2 Biocon Product Introduction, Application and Specification
- 8.5.3 Biocon Remicade Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Hospira
- 8.6.1 Hospira Remicade Biosimilar Production Sites and Area Served
- 8.6.2 Hospira Product Introduction, Application and Specification
- 8.6.3 Hospira Remicade Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Merck Serono (Merck Group)
- 8.7.1 Merck Serono (Merck Group) Remicade Biosimilar Production Sites and Area Served
- 8.7.2 Merck Serono (Merck Group) Product Introduction, Application and Specification
- 8.7.3 Merck Serono (Merck Group) Remicade Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Biogen idec Inc.
- 8.8.1 Biogen idec Inc. Remicade Biosimilar Production Sites and Area Served
- 8.8.2 Biogen idec Inc. Product Introduction, Application and Specification
- 8.8.3 Biogen idec Inc. Remicade Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Genentech (Roche Group)
- 8.9.1 Genentech (Roche Group) Remicade Biosimilar Production Sites and Area Served
- 8.9.2 Genentech (Roche Group) Product Introduction, Application and Specification
- 8.9.3 Genentech (Roche Group) Remicade Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Remicade Biosimilar Market
- 9.1 Global Remicade Biosimilar Market Trend Analysis
- 9.1.1 Global Remicade Biosimilar Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Remicade Biosimilar Regional Market Trend
- 9.2.1 North America Remicade Biosimilar Forecast 2019-2025
- 9.2.2 Europe Remicade Biosimilar Forecast 2019-2025
- 9.2.3 China Remicade Biosimilar Forecast 2019-2025
- 9.2.4 Japan Remicade Biosimilar Forecast 2019-2025
- 9.2.5 Southeast Asia Remicade Biosimilar Forecast 2019-2025
- 9.2.6 India Remicade Biosimilar Forecast 2019-2025
- 9.3 Remicade Biosimilar Market Trend (Product Type)
- 9.4 Remicade Biosimilar Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Remicade Biosimilar Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Remicade Biosimilar. Industry analysis & Market Report on Remicade Biosimilar is a syndicated market report, published as Global Remicade Biosimilar Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Remicade Biosimilar market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
